puberty blockers

A children's hospital admitted to administering puberty blockers to twice as many kids in one year as previously documented over five years, indicating a significant increase in the number of children affected. The article suggests this trend may be harming more children than previously believed.

The Health Secretary expressed unease over the use of puberty blockers on children, while MPs highlighted concerns about insufficient support for patients who detransition. The article underscores growing scrutiny of medical interventions and post-treatment care for minors.

The Federal Trade Commission and multiple state attorneys general are suing the World Professional Association for Transgender Health (WPATH), alleging its guidelines for transgender youth treatments lack sufficient evidence. The lawsuit claims WPATH promoted its Standards of Care as evidence-based despite internal admissions of research gaps, including from lead authors who acknowledged limited data supporting recommendations for puberty blockers, hormones, and surgeries for minors.

The Federal Trade Commission and multiple state attorneys general are suing the World Professional Association for Transgender Health (WPATH) over allegations that its youth treatment guidelines for puberty blockers, hormones, and surgeries were based on limited evidence. The lawsuit claims WPATH leaders privately acknowledged gaps in research while publicly promoting the guidelines as evidence-based.

Children as young as 11 are to be given puberty blockers in a controversial trial. Campaigners are urging courts to shut down the trial, calling it an 'unethical experiment.'

The Federal Trade Commission and four states sued the World Professional Association for Transgender Health (WPATH), alleging the organization misled parents by promoting pediatric medical transition services with unproven science. WPATH defended itself, stating the FTC lacks jurisdiction and that its guidelines are based on scientific standards and patient-centered values.

Sage, a nonbinary high school student, stopped taking testosterone after developing PMOS, a hormonal disorder causing hair growth and irregular periods. Their doctor prescribed puberty blockers to manage PMOS symptoms, not explicitly for trans-related reasons, while a hospital closure impacted trans patient care.

A CBBC medical presenter is accused of leading a 'trans mob' to storm a conference over puberty blockers. The incident highlights tensions in the medical community regarding transgender youth care.